It has been shown that PD-L1-rich exosomes derived from NSCLC cells reduce the sensitivity of some NSCLC cell subsets to cisplatin by inducing cancer stem cells (CSCs) to maintain their heterogeneity [105,106]. Here, CD274 is linked to cancer.